Stay updated on Nelotanserin for Visual Hallucinations in Lewy Body Dementia Clinical Trial
Sign up to get notified when there's something new on the Nelotanserin for Visual Hallucinations in Lewy Body Dementia Clinical Trial page.

Latest updates to the Nelotanserin for Visual Hallucinations in Lewy Body Dementia Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe webpage has added new drug and device information, study documents, and helpful links related to Nelotanserin provided by Sio Gene Therapies. There are no significant deletions that impact core content or important information.SummaryDifference4%
- Check46 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check53 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check68 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check75 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.4%
- Check104 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the location details.SummaryDifference4%
Stay in the know with updates to Nelotanserin for Visual Hallucinations in Lewy Body Dementia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nelotanserin for Visual Hallucinations in Lewy Body Dementia Clinical Trial page.